geneXplain
Healthcare Software · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
b-302 160 Dongtanbanseok-ro, Hwaseong-si...Phone Number
+49 53319922000Website
www.genexplain.comRevenue
<$5 MillionIndustry
About geneXplain
geneXplain Org Chart
Is geneXplain your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when geneXplain launches new products
Check out if geneXplain is spiking on competitors!
Earning: See what the market has to say on geneXplain recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if geneXplain has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once geneXplain has new funding data
Click to see if geneXplain had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at geneXplain
geneXplain, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at geneXplain
Find 2 more new buyers
Company Profile Activity
Activity Insights
geneXplain is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
geneXplain is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about geneXplain.
geneXplain Tech Stack
A closer look at the technologies used by geneXplain
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding geneXplain
GeneXplain GmbH specializes in bioinformatics solutions, offering high-quality databases and tools for gene regulation, drug discovery, and pathway analysis. Their flagship products include TRANSFAC for gene regulation, Chemo-Informatics for predicting drug activity, and BRENDA for enzyme and metabolic pathway modeling. With over 200,000 users and... Read More